635 related articles for article (PubMed ID: 23475416)
21. Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells.
Haugaard SB; Andersen O; Dela F; Holst JJ; Storgaard H; Fenger M; Iversen J; Madsbad S
Eur J Endocrinol; 2005 Jan; 152(1):103-12. PubMed ID: 15762193
[TBL] [Abstract][Full Text] [Related]
22. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A
Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783
[TBL] [Abstract][Full Text] [Related]
23. Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.
Miyamoto L; Ebihara K; Kusakabe T; Aotani D; Yamamoto-Kataoka S; Sakai T; Aizawa-Abe M; Yamamoto Y; Fujikura J; Hayashi T; Hosoda K; Nakao K
J Biol Chem; 2012 Nov; 287(48):40441-7. PubMed ID: 23024365
[TBL] [Abstract][Full Text] [Related]
24. Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes.
Meek TH; Matsen ME; Damian V; Cubelo A; Chua SC; Morton GJ
Endocrinology; 2014 Nov; 155(11):4157-67. PubMed ID: 25137027
[TBL] [Abstract][Full Text] [Related]
25. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy.
Asilmaz E; Cohen P; Miyazaki M; Dobrzyn P; Ueki K; Fayzikhodjaeva G; Soukas AA; Kahn CR; Ntambi JM; Socci ND; Friedman JM
J Clin Invest; 2004 Feb; 113(3):414-24. PubMed ID: 14755338
[TBL] [Abstract][Full Text] [Related]
26. The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction.
Gorden P; Park JY
Arch Physiol Biochem; 2006 Apr; 112(2):114-8. PubMed ID: 16931453
[TBL] [Abstract][Full Text] [Related]
27. The long road to leptin.
Friedman J
J Clin Invest; 2016 Dec; 126(12):4727-4734. PubMed ID: 27906690
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy in a woman with congenital generalized lipodystrophy: leptin's vital role in reproduction.
Maguire M; Lungu A; Gorden P; Cochran E; Stratton P
Obstet Gynecol; 2012 Feb; 119(2 Pt 2):452-455. PubMed ID: 22270436
[TBL] [Abstract][Full Text] [Related]
29. Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy.
Beltrand J; Beregszaszi M; Chevenne D; Sebag G; De Kerdanet M; Huet F; Polak M; Tubiana-Rufi N; Lacombe D; De Paoli AM; Levy-Marchal C
Pediatrics; 2007 Aug; 120(2):e291-6. PubMed ID: 17671040
[TBL] [Abstract][Full Text] [Related]
30. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
[TBL] [Abstract][Full Text] [Related]
31. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.
Koutkia P; Meininger G; Canavan B; Breu J; Grinspoon S
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E296-303. PubMed ID: 14559725
[TBL] [Abstract][Full Text] [Related]
32. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
[TBL] [Abstract][Full Text] [Related]
33. Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives.
Tchang BG; Shukla AP; Aronne LJ
Expert Opin Biol Ther; 2015 Jul; 15(7):1061-75. PubMed ID: 26063386
[TBL] [Abstract][Full Text] [Related]
34. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.
Brown RJ; Oral EA; Cochran E; Araújo-Vilar D; Savage DB; Long A; Fine G; Salinardi T; Gorden P
Endocrine; 2018 Jun; 60(3):479-489. PubMed ID: 29644599
[TBL] [Abstract][Full Text] [Related]
35. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.
Estrada V; Serrano-Ríos M; Martínez Larrad MT; Villar NG; González López A; Téllez MJ; Fernández C
J Acquir Immune Defic Syndr; 2002 Jan; 29(1):32-40. PubMed ID: 11782587
[TBL] [Abstract][Full Text] [Related]
36. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.
Havel PJ
Curr Opin Lipidol; 2002 Feb; 13(1):51-9. PubMed ID: 11790963
[TBL] [Abstract][Full Text] [Related]
37. Treatment Options for Lipodystrophy in Children.
Mainieri F; Tagi VM; Chiarelli F
Front Endocrinol (Lausanne); 2022; 13():879979. PubMed ID: 35600578
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.
Ebihara K; Kusakabe T; Hirata M; Masuzaki H; Miyanaga F; Kobayashi N; Tanaka T; Chusho H; Miyazawa T; Hayashi T; Hosoda K; Ogawa Y; DePaoli AM; Fukushima M; Nakao K
J Clin Endocrinol Metab; 2007 Feb; 92(2):532-41. PubMed ID: 17118991
[TBL] [Abstract][Full Text] [Related]
39. Leptin in humans: lessons from translational research.
Blüher S; Mantzoros CS
Am J Clin Nutr; 2009 Mar; 89(3):991S-997S. PubMed ID: 19176740
[TBL] [Abstract][Full Text] [Related]
40. Leptin-replacement therapy for lipodystrophy.
Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
N Engl J Med; 2002 Feb; 346(8):570-8. PubMed ID: 11856796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
